355P EVERolimus effectiveness after proGREssion on CDK4/6 inhibitors for ENdocrine receptor-positive/HER2-negative, advanced breast cancer: EVERGREEN quasi-experimental study
| Autor: | Lobo-Martins, S.L., Branco, D. Martins, Aftimos, P.G., Pereira, B.A., Matos, A.L.V., Fernandes, L.M. Raposo, Campoa, E.F. Reis, Marta, G. Nader, Moreau, M., Donatienne, T., Duhoux, F.P., Simões, P., Garcia, A.R. Meira, Patel, V.D.C., Confente, C., Costa, D. Alpuim, Pereira, J.R., Santos, C., Ameye, L., de Azambuja, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S365-S366 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|